Connection

Elizabeth Garrett-Mayer to Colonic Neoplasms

This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Colonic Neoplasms.
Connection Strength

0.324
  1. Reduction in promotor methylation utilizing EGCG (epigallocatechin-3-gallate) restores RXRa expression in human colon cancer cells. Oncotarget. 2016 Jun 07; 7(23):35313-26.
    View in: PubMed
    Score: 0.108
  2. Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner. J Biol Chem. 2015 May 22; 290(21):13157-67.
    View in: PubMed
    Score: 0.100
  3. The expression ratio of Map7/B2M is prognostic for survival in patients with stage II colon cancer. Int J Oncol. 2008 Sep; 33(3):579-84.
    View in: PubMed
    Score: 0.063
  4. Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial death signaling. Cancer Res. 2006 Feb 01; 66(3):1730-9.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.